OST-08267

N/A

Report date: 2025/07/09 11:08:14
NME

Base Information

Drug NameOST-08267
Drug Alias NameOST-08267
ClassificationSmall molecules > Molecular GlueSmall molecules > Heterocyclic drugs
Mechanisms of ActionPDE3A-SLFN12 protein complex formation inducers
TargetscGMP-inhibited 3',5'-cyclic phosphodiesterase ASchlafen family member 12
Therapy Area/IndicationsGastrointestinal Stromal Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesOpen Source Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOpen Source Therapeutics
Inactive CompaniesN/A
Active IndicationsGastrointestinal Stromal Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A